While combined treatments with chemotherapy and ICI targeting PD-1/PD-L1 signaling have been effective in human non-squamous NSCLC, disappointing results were obtained when administering chemotherapy and anti-CTLA-4 (Table 1). Here, CTLA4 is linked to non-small cell lung carcinoma.